MALDI Imaging Mass Spectrometry - Painting Molecular Pictures

Molecular Oncology

Volumn 4, Issue 6, 2010, Pages 529-538

  Schwamborn, Kristina ^a   Caprioli, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Imaging Mass Spectrometry; Proteomics

Indexed keywords

ERLOTINIB; LIPID; OXALIPLATIN; TRASTUZUMAB; VINBLASTINE;

BREAST CANCER; CANCER RESEARCH; DRUG DISTRIBUTION; DRUG PENETRATION; GLIOMA; HUMAN; LUNG NON SMALL CELL CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; REVIEW;

EID: 78349308405     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.09.002     Document Type: Review

References (69)

1. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
2. Aerni H.R., Cornett D.S., Caprioli R.M. Automated acoustic matrix deposition for MALDI sample preparation. Anal. Chem. 2006, 78:827-834.
3. Agar N.Y., Malcolm J.G., Mohan V., Yang H.W., Johnson M.D., Tannenbaum A., Agar J.N., Black P.M. Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal. Chem 2010.
4. Andersson M., Groseclose M.R., Deutch A.Y., Caprioli R.M. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat. Methods 2008, 5:101-108.
5. Bauer J.A., Chakravarthy A.B., Rosenbluth J.M., Mi D., Seeley E.H., De Matos Granja-Ingram N., Olivares M.G., Kelley M.C., Mayer I.A., Meszoely I.M., Means-Powell J.A., Johnson K.N., Tsai C.J., Ayers G.D., Sanders M.E., Schneider R.J., Formenti S.C., Caprioli R.M., Pietenpol J.A. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin. Cancer Res. 2010, 16:681-690.
6. Becker K.F., Schott C., Hipp S., Metzger V., Porschewski P., Beck R., Nahrig J., Becker I., Hofler H. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 2007, 211:370-378.
7. Bouslimani A., Bec N., Glueckmann M., Hirtz C., Larroque C. Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Commun. Mass Spectrom. 2010, 24:415-421.
8. Burnum K.E., Cornett D.S., Puolitaival S.M., Milne S.B., Myers D.S., Tranguch S., Brown H.A., Dey S.K., Caprioli R.M. Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J. Lipid Res. 2009, 50:2290-2298.
9. Caldwell R.L., Gonzalez A., Oppenheimer S.R., Schwartz H.S., Caprioli R.M. Molecular assessment of the tumor protein microenvironment using imaging mass spectrometry. Cancer Genomics Proteomics 2006, 3:279-288.
10. Caprioli R.M., Farmer T.B., Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 1997, 69:4751-4760.
11. Cazares L.H., Troyer D., Mendrinos S., Lance R.A., Nyalwidhe J.O., Beydoun H.A., Clements M.A., Drake R.R., Semmes O.J. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin. Cancer Res. 2009, 15:5541-5551.
12. Celis J.E., Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003, 3:9-15.
13. Chaurand P., Caprioli R.M. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002, 23:3125-3135.
14. Chaurand P., Schwartz S.A., Billheimer D., Xu B.J., Crecelius A., Caprioli R.M. Integrating histology and imaging mass spectrometry. Anal. Chem. 2004, 76:1145-1155.
15. Chaurand P., Schwartz S.A., Caprioli R.M. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr. Opin. Chem. Biol. 2002, 6:676-681.
16. Chaurand P., Schwartz S.A., Reyzer M.L., Caprioli R.M. Imaging mass spectrometry: principles and potentials. Toxicol. Pathol. 2005, 33:92-101.
17. Chen E.I., Yates J.R. Cancer proteomics by quantitative shotgun proteomics. Mol. Oncol. 2007, 1:144-159.
18. Cornett D.S., Frappier S.L., Caprioli R.M. MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal. Chem. 2008, 80:5648-5653.
19. Cornett D.S., Mobley J.A., Dias E.C., Andersson M., Arteaga C.L., Sanders M.E., Caprioli R.M. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol. Cell. Proteomics 2006, 5:1975-1983.
20. Cornett D.S., Reyzer M.L., Chaurand P., Caprioli R.M. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods 2007, 4:828-833.
21. Crecelius A.C., Cornett D.S., Caprioli R.M., Williams B., Dawant B.M., Bodenheimer B. Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 2005, 16:1093-1099.
22. Deininger S.O., Ebert M.P., Futterer A., Gerhard M., Rocken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J. Proteome Res. 2008, 7:5230-5236.
23. Djidja M.C., Claude E., Snel M.F., Francese S., Scriven P., Carolan V., Clench M.R. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal. Bioanal. Chem 2010.
24. Djidja M.C., Claude E., Snel M.F., Scriven P., Francese S., Carolan V., Clench M.R. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J. Proteome Res. 2009, 8:4876-4884.
25. Grey A.C., Chaurand P., Caprioli R.M., Schey K.L. MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue. J. Proteome Res. 2009, 8:3278-3283.
26. Groseclose M.R., Massion P.P., Chaurand P., Caprioli R.M. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008, 8:3715-3724.
27. Gustafsson J.O., Oehler M.K., McColl S.R., Hoffmann P. Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. J. Proteome Res. 2010, 9:4315-4328.
28. Hankin J.A., Barkley R.M., Murphy R.C. Sublimation as a method of matrix application for mass spectrometric imaging. J. Am. Soc. Mass Spectrom. 2007, 18:1646-1652.
29. Hanselmann M., Köthe U., Kirchner M., Renard B.Y., Amstalden E.R., Glunde K., Heeren R.M.A., Hamprecht F.A. Toward digital staining using imaging mass spectrometry and random forests. J. Proteome Res. 2009, 8:3558-3567.
30. Harvey D.J., Naven T.J., Kuster B., Bateman R.H., Green M.R., Critchley G. Comparison of fragmentation modes for the structural determination of complex oligosaccharides ionized by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 1995, 9:1556-1561.
31. Herring K.D., Oppenheimer S.R., Caprioli R.M. Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology. Semin. Nephrol. 2007, 27:597-608.
32. Kang S., Shim H.S., Lee J.S., Kim D.S., Kim H.Y., Hong S.H., Kim P.S., Yoon J.H., Cho N.H. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J. Proteome Res. 2010, 9:1157-1164.
33. Karas M., Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60:2299-2301.
34. Khatib-Shahidi S., Andersson M., Herman J.L., Gillespie T.A., Caprioli R.M. Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 2006, 78:6448-6456.
35. Krieg R.C., Gaisa N.T., Paweletz C.P., Knuechel R. Proteomic analysis of human bladder tissue using SELDI approach following microdissection techniques. Methods Mol. Biol. 2005, 293:255-267.
36. Krieg R.C., Paweletz C.P., Liotta L.A., Petricoin E.F. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Technol. Cancer Res. Treat. 2002, 1:263-272.
37. Kruse R., Sweedler J.V. Spatial profiling invertebrate ganglia using MALDI MS. J. Am. Soc. Mass Spectrom. 2003, 14:752-759.
38. Lemaire R., Ait Menguellet S., Stauber J., Marchaudon V., Lucot J.-P., Collinet P., Farine M.-O., Vinatier D., Day R., Ducoroy P., Salzet M., Fournier I. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, reg alpha fragment, is a new potential ovary cancer biomarker. J. Proteome Res. 2007, 6:4127-4134.
39. Mackay A., Jones C., Dexter T., Silva R.L., Bulmer K., Jones A., Simpson P., Harris R.A., Jat P.S., Neville A.M., Reis L.F., Lakhani S.R., O'Hare M.J. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) over expression in human mammary luminal epithelial cells. Oncogene 2003, 22:2680-2688.
40. Mueller C., Liotta L.A., Espina V. Reverse phase protein microarrays advance to use in clinical trials. Mol. Oncol 2010, 4(6):461-481.
41. Oppenheimer S.R., Mi D., Sanders M., Caprioli R.M. A molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J. Proteome Res. 2010.
42. Patel S.A., Barnes A., Loftus N., Martin R., Sloan P., Thakker N., Goodacre R. Imaging mass spectrometry using chemical inkjet printing reveals differential protein expression in human oral squamous cell carcinoma. Analyst 2009, 134:301-307.
43. Puolitaival S.M., Burnum K.E., Cornett D.S., Caprioli R.M. Solvent-free matrix dry-coating for MALDI imaging of phospholipids. J. Am. Soc. Mass Spectrom. 2008, 19:882-886.
44. Rauser S., Marquardt C., Balluff B., Deininger S.O., Albers C., Belau E., Hartmer R., Suckau D., Specht K., Ebert M.P., Schmitt M., Aubele M., Hofler H., Walch A. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J. Proteome Res 2010.
45. Reyzer M.L., Caldwell R.L., Dugger T.C., Forbes J.T., Ritter C.A., Guix M., Arteaga C.L., Caprioli R.M. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res. 2004, 64:9093-9100.
46. Reyzer M.L., Hsieh Y., Ng K., Korfmacher W.A., Caprioli R.M. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 2003, 38:1081-1092.
47. Ronci M., Bonanno E., Colantoni A., Pieroni L., Di Ilio C., Spagnoli L.G., Federici G., Urbani A. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics 2008, 8:3702-3714.
48. Schiller J., Suss R., Arnhold J., Fuchs B., Lessig J., Muller M., Petkovic M., Spalteholz H., Zschornig O., Arnold K. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog. Lipid Res. 2004, 43:449-488.
49. Schwamborn K., Krieg R., Jirak P., Ott G., Knüchel R., Rosenwald A., Wellmann A. Application of MALDI imaging for the diagnosis of classical hodgkin lymphoma. J. Cancer Res. Clin. Oncol 2010.
50. Schwamborn K., Krieg R.C., Reska M., Jakse G., Knuechel R., Wellmann A. Identifying prostate carcinoma by MALDI-Imaging. Int. J. Mol. Med. 2007, 20:155-159.
51. Schwartz S.A., Reyzer M.L., Caprioli R.M. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J. Mass Spectrom. 2003, 38:699-708.
52. Schwartz S.A., Weil R.J., Thompson R.C., Shyr Y., Moore J.H., Toms S.A., Johnson M.D., Caprioli R.M. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 2005, 65:7674-7681.
53. Seeley E.H., Caprioli R.M. Molecular imaging of proteins in tissues by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18126-18131.
54. Signor L., Varesio E., Staack R.F., Starke V., Richter W.F., Hopfgartner G. Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry. J. Mass Spectrom. 2007, 42:900-909.
55. Sinha T.K., Khatib-Shahidi S., Yankeelov T.E., Mapara K., Ehtesham M., Cornett D.S., Dawant B.M., Caprioli R.M., Gore J.C. Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat. Methods 2008, 5:57-59.
56. Sloane A.J., Duff J.L., Wilson N.L., Gandhi P.S., Hill C.J., Hopwood F.G., Smith P.E., Thomas M.L., Cole R.A., Packer N.H., Breen E.J., Cooley P.W., Wallace D.B., Williams K.L., Gooley A.A. High throughput peptide mass fingerprinting and protein macroarray analysis using chemical printing strategies. Mol. Cell. Proteomics 2002, 1:490-499.
57. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 2001, 7:493-496.
58. Tanaka K., Waki H., Ido Y., Akita S., Yoshida Y., Yoshida T., Matsuo T. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 1988, 2:151-153.
59. Tost J., Gut I.G. DNA analysis by mass spectrometry-past, present and future. J. Mass Spectrom. 2006, 41:981-995.
60. Trim P.J., Henson C.M., Avery J.L., McEwen A., Snel M.F., Claude E., Marshall P.S., West A., Princivalle A.P., Clench M.R. Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal. Chem. 2008, 80:8628-8634.
61. van der Merwe D.E., Oikonomopoulou K., Marshall J., Diamandis E.P. Mass spectrometry: uncovering the cancer proteome for diagnostics. Adv. Cancer Res. 2007, 96:23-50.
62. Wagner M., Varesio E., Hopfgartner G. Ultra-fast quantitation of saquinavir in human plasma by matrix-assisted laser desorption/ionization and selected reaction monitoring mode detection. J. Chromatogr. B. 2008, 872:68-76.
63. Walch A., Rauser S., Deininger S.O., Hofler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem. Cell Biol. 2008, 130:421-434.
64. Wang H.Y., Jackson S.N., Woods A.S. Direct MALDI-MS analysis of cardiolipin from rat organs sections. J. Am. Soc. Mass Spectrom. 2007, 18:567-577.
65. Wenk M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 2005, 4:594-610.
66. Wilson K.S., Roberts H., Leek R., Harris A.L., Geradts J. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. Am. J. Pathol. 2002, 161:1171-1185.
67. Wisztorski M., Franck J., Salzet M., Fournier I. MALDI direct analysis and imaging of frozen versus FFPE tissues: what strategy for which sample?. Methods Mol. Biol. 2010, 656:303-322.
68. Xu H., Yang L., Wang W., Shi S.R., Liu C., Liu Y., Fang X., Taylor C.R., Lee C.S., Balgley B.M. Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues. J. Proteome Res. 2008, 7:1098-1108.
69. Yanagisawa K., Shyr Y., Xu B.J., Massion P.P., Larsen P.H., White B.C., Roberts J.R., Edgerton M., Gonzalez A., Nadaf S., Moore J.H., Caprioli R.M., Carbone D.P. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003, 362:433-439.